Metropolis Healthcare Ltd

Mutations or abnormalities in the BRCA1 (BReast CAncer Gene 1) and BRCA2 genes are the most common cause of hereditary breast cancer. In the Indian population, there is a higher proportion of BRCA1- associated breast cancer (66%) than BRCA2 (45%). Men with a BRCA mutation, especially BRCA2 are also at a higher risk of Breast Cancer (6-8%). Dr. Aparna Rajadhyaksha, Medical Consultant, Metropolis Healthcare contributes an insightful article to The New Indian Express explaining the significance of Breast Cancer Gene Testing and its impact on treatment. To read the online version, click here: https://www.newindianexpress.com/cities/kochi/2022/jul/05/breast-cancer-genetic-testing-impact-and-advantages-2472883.html#BRCA1 #BRCA2 #BreastCancer #OvarianCancer #LungCancer #Genetesting #ProstateCancer #Genomexpert #Oncomet #ScientificExcellence #MetropolisInnovationCell #MolecularOncology #BRCA1 #BRCA2 #BreastCancer #OvarianCancer #LungCancer #Genetesting #ProstateCancer #Genomexpert #Oncomet #ScientificExcellence #MetropolisInnovationCell #MolecularOncology

#ProstateCancer is the second most frequent cancer and the fifth leading cause of cancer death among men. Since it is a slow growing tumour, doctors suggest that an early detection leads to better chances of successful treatment. Prostate-Specific Antigen (PSA) test has been proven to be an efficient, easy, and cost-effective method of screening for prostate cancer. Here’s our research study reinforcing the importance of PSA screening test, which has been published in the International Journal of Health Sciences and Research. This study showed a statistical correlation of age and PSA with prostatic carcinoma identified through prostatic core needle biopsies. The risk of cancer is minimal with a PSA less than 4 ng/ml whereas an elevated PSA is associated with pathology and hence even a borderline elevation should not be ignored. We congratulate and thank all our doctors Kunjal Lila, Dr. Kirti Chadha, Dr. Shaikhali M Barodawala, Dr. Vikas S Kavishwar and Dr. Anuradha K Murthy for contributing to this research study. #ProstateCancer